These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 29023759)

  • 21. Expansion of T Cells with Interleukin-21 for Adoptive Immunotherapy of Murine Mammary Carcinoma.
    Zoon CK; Wan W; Graham L; Bear HD
    Int J Mol Sci; 2017 Jan; 18(2):. PubMed ID: 28146052
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intracellular cytokine profile of cord blood T-, and NK- cells and monocytes.
    Krampera M; Tavecchia L; Benedetti F; Nadali G; Pizzolo G
    Haematologica; 2000 Jul; 85(7):675-9. PubMed ID: 10897117
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic modification of T cells with IL-21 enhances antigen presentation and generation of central memory tumor-specific cytotoxic T-lymphocytes.
    Kaka AS; Shaffer DR; Hartmaier R; Leen AM; Lu A; Bear A; Rooney CM; Foster AE
    J Immunother; 2009 Sep; 32(7):726-36. PubMed ID: 19561536
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Flow cytometric characterization of human umbilical cord blood lymphocytes: immunophenotypic features.
    D'Arena G; Musto P; Cascavilla N; Di Giorgio G; Fusilli S; Zendoli F; Carotenuto M
    Haematologica; 1998 Mar; 83(3):197-203. PubMed ID: 9573672
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epstein-Barr virus-transformed B-cells as efficient antigen presenting cells to propagate Aspergillus-specific cytotoxic T-lymphocytes.
    Ramadan G
    Egypt J Immunol; 2008; 15(1):145-57. PubMed ID: 20306679
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Umbilical cord blood T cells respond against the Melan-A/MART-1 tumor antigen and exhibit reduced alloreactivity as compared with adult blood-derived T cells.
    Merindol N; Grenier AJ; Caty M; Charrier E; Duval A; Duval M; Champagne MA; Soudeyns H
    J Immunol; 2010 Jul; 185(2):856-66. PubMed ID: 20543110
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Generation of cytotoxic effector lymphocytes by MLTC using tumor cells genetically modified to secrete interleukin-2.
    Yamaguchi Y; Ohta K; Shimizu K; Minami K; Noma K; Hihara J; Toge T
    Anticancer Res; 2001; 21(1B):669-77. PubMed ID: 11299824
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selective responsiveness to common gamma chain cytokines in peripheral blood-derived cytotoxic T lymphocytes induced by Melan-A/MART-1(27-35)targeted active specific immunotherapy.
    von Holzen U; Adamina M; Bolli M; Weber WP; Zajac P; Groeper C; Reschner A; Feder C; Schumacher R; Marti W; Oertli D; Heberer M; Spagnoli GC
    Int J Cancer; 2005 Jun; 115(2):248-55. PubMed ID: 15688403
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combining dasatinib with dexamethasone long-term leads to maintenance of antiviral and antileukemia specific cytotoxic T cell responses in vitro.
    Nerreter T; Distler E; Köchel C; Einsele H; Herr W; Seggewiss-Bernhardt R
    Exp Hematol; 2013 Jul; 41(7):604-614.e4. PubMed ID: 23466625
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interleukin-7 permits Th1/Tc1 maturation and promotes ex vivo expansion of cord blood T cells: a critical step toward adoptive immunotherapy after cord blood transplantation.
    Davis CC; Marti LC; Sempowski GD; Jeyaraj DA; Szabolcs P
    Cancer Res; 2010 Jul; 70(13):5249-58. PubMed ID: 20530666
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunophenotypic and functional characterization of cord blood dendritic cells.
    Crespo I; Paiva A; Couceiro A; Pimentel P; Orfão A; Regateiro F
    Stem Cells Dev; 2004 Feb; 13(1):63-70. PubMed ID: 15068694
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human effector T cells derived from central memory cells rather than CD8(+)T cells modified by tumor-specific TCR gene transfer possess superior traits for adoptive immunotherapy.
    Wu F; Zhang W; Shao H; Bo H; Shen H; Li J; Liu Y; Wang T; Ma W; Huang S
    Cancer Lett; 2013 Oct; 339(2):195-207. PubMed ID: 23791878
    [TBL] [Abstract][Full Text] [Related]  

  • 33. T lymphocytes derived from human cord blood provide effective antitumor immunotherapy against a human tumor.
    Lee YS; Kim TS; Kim DK
    BMC Cancer; 2011 Jun; 11():225. PubMed ID: 21649881
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coexistent naïve phenotype and higher cycling rate of cord blood T cells as compared to adult peripheral blood.
    Szabolcs P; Park KD; Reese M; Marti L; Broadwater G; Kurtzberg J
    Exp Hematol; 2003 Aug; 31(8):708-14. PubMed ID: 12901976
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Generation of Pure Highly Functional Human Anti-Tumor Specific Cytotoxic T Lymphocytes With Stem Cell-Like Memory Features for Melanoma Immunotherapy.
    Hamieh M; Chatillon JF; Dupel E; Bayeux F; Fauquembergue E; Maby P; Drouet A; Duval-Modeste AB; Adriouch S; Boyer O; Latouche JB
    Front Immunol; 2021; 12():674276. PubMed ID: 34566953
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction of cytotoxic T-lymphocytes specific for malignant glioma by HLA dimer-based artificial antigen-presenting cells.
    Xiaobing J; Xiaoling L; Ruen L; Fangcheng Z; Hongyang Z
    Cancer Biother Radiopharm; 2007 Dec; 22(6):826-35. PubMed ID: 18158774
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rapid Expansion of Highly Functional Antigen-Specific T Cells from Patients with Melanoma by Nanoscale Artificial Antigen-Presenting Cells.
    Ichikawa J; Yoshida T; Isser A; Laino AS; Vassallo M; Woods D; Kim S; Oelke M; Jones K; Schneck JP; Weber JS
    Clin Cancer Res; 2020 Jul; 26(13):3384-3396. PubMed ID: 32241816
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cord blood comprises antigen-experienced T cells specific for maternal minor histocompatibility antigen HA-1.
    Mommaas B; Stegehuis-Kamp JA; van Halteren AG; Kester M; Enczmann J; Wernet P; Kögler G; Mutis T; Brand A; Goulmy E
    Blood; 2005 Feb; 105(4):1823-7. PubMed ID: 15498856
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Unique effects of mycophenolate mofetil on cord blood T cells: implications for GVHD prophylaxis.
    Derniame S; Lee F; Domogala A; Madrigal A; Saudemont A
    Transplantation; 2014 Apr; 97(8):870-8. PubMed ID: 24670298
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Derivation of human T lymphocytes from cord blood and peripheral blood with antiviral and antileukemic specificity from a single culture as protection against infection and relapse after stem cell transplantation.
    Micklethwaite KP; Savoldo B; Hanley PJ; Leen AM; Demmler-Harrison GJ; Cooper LJ; Liu H; Gee AP; Shpall EJ; Rooney CM; Heslop HE; Brenner MK; Bollard CM; Dotti G
    Blood; 2010 Apr; 115(13):2695-703. PubMed ID: 20110422
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.